» Articles » PMID: 38398409

Screening for Subclinical Atherosclerosis and the Prediction of Cardiovascular Events in People with Type 1 Diabetes

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Feb 24
PMID 38398409
Authors
Affiliations
Soon will be listed here.
Abstract

People with type 1 diabetes (T1D) have a high cardiovascular disease (CVD) risk, which remains the leading cause of death in this population. Despite the improved control of several classic risk factors, particularly better glycaemic control, cardiovascular morbidity and mortality continue to be significantly higher than in the general population. In routine clinical practice, estimating cardiovascular risk (CVR) in people with T1D using scales or equations is often imprecise because much of the evidence comes from pooled samples of people with type 2 diabetes (T2D) and T1D or from extrapolations of studies performed on people with T2D. Given that T1D onsets at a young age, prolonged exposure to the disease and its consequences (e.g., hyperglycaemia, changes in lipid metabolism or inflammation) have a detrimental impact on cardiovascular health. Therefore, it is critical to have tools that allow for the early identification of those individuals with a higher CVR and thus be able to make the most appropriate management decisions in each case. In this sense, atherosclerosis is the prelude to most cardiovascular events. People with diabetes present pathophysiological alterations that facilitate atherosclerosis development and that may imply a greater vulnerability of atheromatous plaques. Screening for subclinical atherosclerosis using various techniques, mainly imaging, has proven valuable in predicting cardiovascular events. Its use enables the reclassification of CVR and, therefore, an individualised adjustment of therapeutic management. However, the available evidence in people with T1D is scarce. This narrative review provides and updated overview of the main non-invasive tests for detecting atherosclerosis plaques and their association with CVD in people with T1D.

Citing Articles

Association between the GMI/HbA1c ratio and preclinical carotid atherosclerosis in type 1 diabetes: impact of the fast-glycator phenotype across age groups.

Puig-Jove C, Vinals C, Conget I, Quiros C, Vinagre I, Berrocal B Cardiovasc Diabetol. 2025; 24(1):75.

PMID: 39953520 PMC: 11829493. DOI: 10.1186/s12933-025-02637-4.


Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes.

Sojo-Vega L, Recasens M, Martinez J, Aguilera A, Ayala M, Admetlla N Cardiovasc Diabetol. 2024; 23(1):366.

PMID: 39420367 PMC: 11488122. DOI: 10.1186/s12933-024-02455-0.

References
1.
Forstermann U, Xia N, Li H . Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ Res. 2017; 120(4):713-735. DOI: 10.1161/CIRCRESAHA.116.309326. View

2.
Katakami N . Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus. J Atheroscler Thromb. 2017; 25(1):27-39. PMC: 5770221. DOI: 10.5551/jat.RV17014. View

3.
Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y . Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population: An individual participant data meta-analysis. Atherosclerosis. 2018; 275:141-148. DOI: 10.1016/j.atherosclerosis.2018.05.048. View

4.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

5.
Ato D . Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity. Vasc Health Risk Manag. 2018; 14:41-62. PMC: 5892969. DOI: 10.2147/VHRM.S159437. View